extra tirzepatide in vial Weight Loss Injections Tirzepatide & Semaglutide Weight Loss

The goal is strategic, individualized use based on what your body needs

Mounjaro introduced tirzepatide as a dual GIP/GLP-1 receptor agonist for type 2 diabetes

Similarly, 5% and 9.2% of patients experienced vomiting with 0.5 and 1 mg doses of semaglutide

Initially developed to treat type 2 diabetes, GLP-1 receptor agonists are now widely used for weight loss due to their ability to mimic the hormones natural effects

Dosing Schedule Administration: Once-weekly injection under the skin (subcutaneous) Final dose: 2.4 mg weekly (maintenance dose) Duration: Used long-term alongside diet and exercise Injection Details Use the FlexTouch pre-filled pen Inject into front of upper arm, upper legs, or stomach Same day each week preferred, but can be changed if at least 3 days between doses Most common Nausea (feeling sick) Vomiting (being sick) Diarrhoea Constipation Stomach pain Headache Feeling weak or tired Usually these will resolve over time

Without exercise to keep your metabolism active, the gap between calories consumed and burned shrinks, which can slow down or stall weight loss